Elevated serum soluble CD30 precedes the development of AIDS-associated non-Hodgkin's B cell lymphoma
- PMID: 16651853
- DOI: 10.1159/000093022
Elevated serum soluble CD30 precedes the development of AIDS-associated non-Hodgkin's B cell lymphoma
Abstract
CD30, first described as the Ki antigen on malignant B cells in Hodgkin's lymphoma, is also expressed on normal activated B and T cells. It can be cleaved from the cell surface and detected in normal serum as soluble CD30 (sCD30), where it can be an indicator of levels of immune activation. In a cross-sectional study utilizing archived sera at a time point close to but preceding a diagnosis of acquired immunodeficiency syndrome (AIDS)-associated non-Hodgkin's B cell lymphoma, AIDS lymphoma subjects (n = 49) showed elevated mean levels of sCD30 compared to controls with AIDS but no malignancy (n = 44, p < 0.01), HIV-infected but relatively healthy (n = 47, p < 0.001), or HIV-seronegative controls (n = 44, p < 0.001). Serum sCD30 was significantly correlated to serum levels of the B cell cytokines interleukin-6 (IL-6), IL-10, and sCD23, but only among lymphoma subjects (p < or = 0.05). Correlations between sCD30 and other markers of immune system activation were seen among all HIV-infected subjects (sCD27, sCD44, CXCL13, p < 0.05). These observations suggest that sCD30, especially in combination with other immune system molecules, could be an important biomarker for an immune system environment conducive to B cell hyperactivation and the development of AIDS-associated B cell lymphoma.
Copyright 2006 S. Karger AG, Basel.
Similar articles
-
B-cell stimulatory cytokines and markers of immune activation are elevated several years prior to the diagnosis of systemic AIDS-associated non-Hodgkin B-cell lymphoma.Cancer Epidemiol Biomarkers Prev. 2011 Jul;20(7):1303-14. doi: 10.1158/1055-9965.EPI-11-0037. Epub 2011 Apr 28. Cancer Epidemiol Biomarkers Prev. 2011. PMID: 21527584 Free PMC article.
-
Serum biomarkers of immune activation and subsequent risk of non-hodgkin B-cell lymphoma among HIV-infected women.Cancer Epidemiol Biomarkers Prev. 2013 Nov;22(11):2084-93. doi: 10.1158/1055-9965.EPI-13-0614. Epub 2013 Sep 17. Cancer Epidemiol Biomarkers Prev. 2013. PMID: 24045923 Free PMC article.
-
Aberrant expression of CD27 and soluble CD27 (sCD27) in HIV infection and in AIDS-associated lymphoma.Clin Immunol. 1999 Nov;93(2):114-23. doi: 10.1006/clim.1999.4782. Clin Immunol. 1999. PMID: 10527687
-
Soluble CD30 serum level--an adequate marker for allograft rejection of solid organs?Histol Histopathol. 2007 Nov;22(11):1269-79. doi: 10.14670/HH-22.1269. Histol Histopathol. 2007. PMID: 17647199 Review.
-
CD30 and type 2 T helper (Th2) responses.J Leukoc Biol. 1995 May;57(5):726-30. doi: 10.1002/jlb.57.5.726. J Leukoc Biol. 1995. PMID: 7759952 Review.
Cited by
-
Plasma markers of B-cell activation and clonality in pediatric liver and hematopoietic stem cell transplant recipients.Transplantation. 2013 Feb 15;95(3):519-26. doi: 10.1097/TP.0b013e318274ab63. Transplantation. 2013. PMID: 23222884 Free PMC article.
-
Circulating cytokine levels, Epstein-Barr viremia, and risk of acquired immunodeficiency syndrome-related non-Hodgkin lymphoma.Am J Hematol. 2011 Oct;86(10):875-8. doi: 10.1002/ajh.22119. Am J Hematol. 2011. PMID: 22022727 Free PMC article.
-
HIV-induced immune activation: pathogenesis and clinical relevance - summary of a workshop organized by the German AIDS Society (DAIG e.v.) and the ICH Hamburg, Hamburg, Germany, November 22, 2008.Eur J Med Res. 2010 Jan 29;15(1):1-12. doi: 10.1186/2047-783x-15-1-1. Eur J Med Res. 2010. PMID: 20159665 Free PMC article.
-
Effect of highly active antiretroviral therapy on biomarkers of B-lymphocyte activation and inflammation.AIDS. 2011 Jan 28;25(3):303-14. doi: 10.1097/QAD.0b013e32834273ad. AIDS. 2011. PMID: 21192231 Free PMC article.
-
Immunologic and virologic predictors of AIDS-related non-hodgkin lymphoma in the highly active antiretroviral therapy era.J Acquir Immune Defic Syndr. 2010 May 1;54(1):78-84. doi: 10.1097/01.qai.0000371677.48743.8d. J Acquir Immune Defic Syndr. 2010. PMID: 20418723 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources